Drug Trial Radar · NCT05202912
Food Effect Study of IDX-1197 in Healthy Subjects
Last checked: Nov 19, 2026Latest source record: Aug 9, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
37
Actual
Start
Jan 16, 2022
Primary completion
Jul 23, 2022
Study completion Jul 23, 2022
Sponsor
- Lead sponsor
- Idience Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jan 24, 2022
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Male only, from 19 years, up to 50 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Study to Evaluate the Effects of Food or Ethnicity on the Pharmacokinetics and Safety/Tolerability of IDX-1197 After Single Oral Administration in Healthy Male Korean, Chinese, and Caucasian Volunteers
Conditions
- Healthy Male
Interventions
IDX-1197(After a meal)Drug
randomized, open-label, single-dose, 2-period, 2-sequence crossover study in healthy male Korean and Caucasian volunteers
IDX-1197(fasting)Drug
open-label, single-dose study in Chinese male volunteers
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cmax of IDX-1197Time frame: through study completion, an average of 1 year
- AUClast of IDX-1197Time frame: through study completion, an average of 1 year
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Seoul National University Hospital
Seoul, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.